MENTRIK Biotech, LLC is pleased to announce that the U.S. Food & Drug Administration (FDA) has granted orphan drug designation to AME-133v (LY2469298), an anti-CD20 monoclonal antibody, for the treatment of follicular lymphoma.
AROG Pharmaceuticals, LLC Announces Presentation of Data on the Activity of Crenolanib Against Mutant PDGFR at 47th American Society of Clinical Oncology Annual Meeting